(Reuters) - Teva Pharmaceutical Industries Ltd on Thursday launched an asthma inhaler that will be the first direct competition to GlaxoSmithKline's best-selling Advair. Teva, which won U.S. approval ...
GAITHERSBURG, Maryland (Reuters) - U.S. regulatory advisers on Wednesday recommended strengthening safety warnings on GlaxoSmithKline Plc's asthma drug Serevent amid new reports of deaths in children ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback